Citations

Showing 10 of 108083 citations.

A Phase 1 First-in-Human Study of Abbv-383, a BCMA × CD3 Bispecific T-Cell-Redirecting Antibody, As Monotherapy in Patients with Relapsed/Refractory Multiple Myeloma
Voorhees, Peter M. , Hurd, David D., Rodriguez, Cesar , Korde, Neha , Safah, Hana, Bueno, Orlando F. , Pumford, Neil R., Rosenberg, Tanya S, Pothacamury, Rajvineeth Kumar, Polepally, Akshanth R. , Talati, Chetasi, Vij, Ravi , Kumar, Shaji , D’Souza, Anita , Weisel, Katja C , Teipel, Raphael , Chung, Alfred , Tuchman, Sascha Alexander , Pumford, Neil, Ross, Jeremy A. , Lee, Shane , Jin, Ziyi , Talati, Chetasi

Mayo Clinic

Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 4401-4404

10.1182/blood-2022-167008 Get It

Evaluating a modified delay-multiply-and-sum reconstruction algorithm to improve detection of osteochondritis dissecans
Holmes, Philip M. , Chen, Kun-Hui , Lee, Hyungkyi, Fitzsimmons, James S. , O’Driscoll, Shawn W. , Urban, Matthew W.

Mayo Clinic

The Journal of the Acoustical Society of America | November 29, 2022 | Volume: 152 | Issue: 4_Supplement | Pages: A184-A184

10.1121/10.0015971 Get It

Osteochondritis dissecans (OCD) is a focal joint defect that is prevalent among youth athletes. With the application of medical ultrasound, OCD of the humeral capitellum could be detected earlier and prevent surgery. In this work, we tested a modified Delay-Multiply-and-Sum (DMAS) reconstruction algorithm to evaluate how it affects medical ultrasound’s ability to detect OCD. Starting with the DMAS reconstruction algorithm described by Matrone et al. (2015), we modified the implementation of filtering and envelope detection steps. Delay-and-Sum (DAS), DMAS, and modified DMAS algorithms were tested on phantom and cadaveric models of capitellar OCD. The DMAS and modified DMAS images were histogram matched to the DAS image for quantitative comparison. By taking several profiles across the images of the artificial OCD lesions, we compared the lesion contrast and bone surface clarity produced by each algorithm. We found that the unmodified DMAS algorithm showed little improvement over the DAS algorithm, particularly after histogram matching. The modified DMAS algorithm showed a much greater improvement in the detection of OCD lesions compared to the DMAS algorithm. This modified DMAS algorithm could be used for other bone surface imaging applications. Future work includes evaluating these algorithms in vivo with patients diagnosed with OCD.
Acoustic comparison and speech-based biomarkers for the detection of gastroesophageal reflux disease: Research-grade versus iPad recordings
Aka, David, Yarlagadda, Manoj K., Buller, Kevin, Kamboj, Amrit K. , Orbelo, Diana M. , Pietrowicz, Mary , Ishikawa, Keiko , Leggett, Cadman L.

Mayo Clinic

The Journal of the Acoustical Society of America | November 29, 2022 | Volume: 152 | Issue: 4_Supplement | Pages: A138-A138

10.1121/10.0015806 Get It

Pietrowicz et al. (2022) demonstrated feasibility of detecting potential speech-based biomarkers to identify gastroesophageal reflux disease (GERD) and Barrett’s esophagus (BE); however, speech samples were obtained using research-grade recording equipment (TASCAM DR-40X with AKG C555L microphone). The use of more readily available equipment such as the Apple iPad with a native microphone could simplify data collection and allow access to a broader range of participants. Therefore, this study compared the research-grade recordings to iPad recordings for feasibility of detecting GERD and BE. One-hundred-fifty adults, clinically classified as GERD negative or GERD positive with or without BE, recorded a paragraph (The Rainbow Passage) simultaneously on both a TASCAM and iPad. Both data sets were analyzed manually for Alpha Ratio and Cepstral Peak Prominence (CPP) with Praat. Initial results show significantly higher alpha ratio and lower CPP in iPad recordings, indicating greater noise energy in the high-frequency range. Additionally, the capability of machine and deep learning model types to discern across GERD negative, GERD positive, BE, and normal voices were compared. Detection across these conditions and comparison of acoustic findings were explored to determine usefulness of the less controlled option of recording using an iPad with its internal microphone.
Comparison of arterial mechanical properties measured with arterial dispersion ultrasound vibrometry and clinical arterial stiffness metrics
Lee, Hyungkyi, Capron, Charles , Lopez‐Jimenez, Francisco, Hesley, Gina K. , Aquino, Wilkins , Greenleaf, James F., Urban, Matthew W. , Roy, Tuhin , López-Jiménez, Francisco , Guddati, Murthy N.

Mayo Clinic

The Journal of the Acoustical Society of America | November 28, 2022 | Volume: 152 | Issue: 4_Supplement | Pages: A47-A47

10.1121/10.0015495 Get It

Arterial stiffness is recognized as a highly clinically relevant and independent prognostic biomarker of cardiovascular disease. Arterial dispersion ultrasound vibrometry (ADUV) uses acoustic radiation force to generate propagating waves in the arterial wall and measures the wave motion to estimate arterial mechanical properties from fitting phase velocity dispersion curves to a waveguide model. ADUV measurements were made with a Verasonics V1 system with a L7-4 linear array transducer in 63 human subjects (27 male/36 female) from ages 50–88 years old. We made measurements at 10 time points within the cardiac cycle, termed cardiac stages. We estimated the phase velocity (median of cp from 400-600 Hz) and G determined from matching the dispersion curves with those from a waveguide model incorporating the artery diameter and wall thickness. Within the same study visit, we measured the intima-media thickness and diameter changes through the cardiac cycle with a General Electric Logiq E9 or E10 scanner. We also tonometry to determine the carotid-femoral pulse wave velocity. We report here comparisons of median phase velocity, cp, and inverted shear modulus, G, at different stages of the cardiac cycle with clinical metrics of arterial stiffness.
Patient-Reported Outcomes in Long-Term Survivors of Autologous Hematopoietic Cell Transplantation for Hodgkin and Non-Hodgkin Lymphoma: Secondary Analysis from Two Multi-Center Randomized Controlled Trials of Hematopoietic Cell Transplant Survivorship Inte
Mian, Agrima , Yi, Jean C. , Preussler, Jaime M. , Hill, Brian T. , Černý, Jan , Deol, Abhinav , Hahn, Theresa , Hashmi, Shahrukh K. , Khera, Nandita , Loren, Alison W. , Stiff, Patrick J. , Uberti, Joseph P., Whalen, Victoria , Reynolds, Jana , Syrjala, Karen L. , Hamilton, Betty K. , Wei, Wei , Chakraborty, Rajshekhar , Jaglowski, Samantha , Jim, Heather , McGuirk, Joseph P. , Savani, Bipin N. , Wingard, John R. , Holtan, Shernan G. , Wood, William A. , Baker, Kevin Scott , Majhail, Navneet S.

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 8019-8021

10.1182/blood-2022-167411 Get It

Abnormal Free Light Chains in Individuals with African Ancestry Screened for Monoclonal Gammopathy: Definition of New Reference Range Accounting for Renal Function and Race
Bertamini, Luca, Murphy, Ciara, Fleming, Grace, Perry, Jacqueline , Cea-Curry, Christian J., Pentz, Audrey , Hlubi, Thulisile, Smyth, Natalie , Sakrikar, D.J., Perkins, Mark, Troske, Derek, Chen, Carl Wenlong, Bertamini, Luca , Alberge, Jean-Baptiste , El‐Khoury, Habib , Lee, David Jungpa , Davis, Maya , Harding, Stephen E. , Getz, Gad , Rebbeck, Timothy R. , Joffe, Maureen , Marinac, Catherine R. , Leung, Nelson , Ghobrial, Irene M.

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 10005-10006

10.1182/blood-2022-164436 Get It

Persistance or Reappearance of Serum Monoclonal Protein Detected By Mass Spectrometry Is a Major Prognostic Factor in Patients with Newly Diagnosed Multiple Myeloma
Murray, David , Kapoor, Prashant , Fonder, Amie , Hayman, Suzanne R. , Hobbs, Miriam, Hwa, Yi L., Kourelis, Taxiarchis , Lacy, Martha Q. , Lin, Yi , Warsame, Rahma , Kyle, Robert A. , Kumar, Shaji , Claveau, Jean‐Sébastien , Dispenzieri, Angela , Binder, Moritz , Buadi, Francis K. , Dingli, David , Gertz, Morie A. , Gonsalves, Wilson I. , Leung, Nelson , Rajkumar, S. Vincent

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 2347-2348

10.1182/blood-2022-167430 Get It

Time to Complete Response within 24 Months As a Good Surrogate Marker of 8 Year-Progression Free Survival in Extranodal Marginal Zone Lymphoma
Conconi, Annarita , Nowakowski, Grzegorz S. , Thiéblemont, Catherine , Bommier, Côme , Zucca, Emanuele , Cerhan, James R. , Lambert, Jérôme

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 3583-3584

10.1182/blood-2022-169805 Get It